SKIN Disorders in the pathology of the digestive organs and malabsorption syndrome in general medical practice

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The article highlights skin disorders in the pathology of the gastrointestinal tract, liver, pancreas, inflammatory bowel diseases and concomitant malabsorption syndrome. Cutaneous vasculitis, erythema nodosum, rosacea, pink acne, pyoderma, atopic dermatitis, psoriasis, etc. they can be comorbid with various pathologies of the digestive organs and manifest themselves before, during or after the detection of pathology of the digestive system. An adequate assessment of skin manifestations by the attending physician and the involvement of related specialists in the therapeutic and diagnostic process will reduce the diagnostic route of the patient and bring him closer to success in the treatment of both skin and somatic pathology.

 

Full Text

Restricted Access

About the authors

Albina A. Gazdanova

I.M. Sechenov First Moscow State Medical University of the Ministry of Healthcare of Russia (Sechenov University)

Author for correspondence.
Email: al.gazdanova@gmail.com
ORCID iD: 0000-0001-7099-4547

PhD in Medical Sciences, associate professor of the Department of clinical pharmacology and propedeutics of internal diseases

Russian Federation, 119435, Moscow, 11/4 Rossolimo Str.

Nadezhda I. Lenkova

I.M. Sechenov First Moscow State Medical University of the Ministry of Healthcare of Russia (Sechenov University)

Email: shunjamur@gmail.com
ORCID iD: 0000-0002-9920-8949

PhD in Medical Sciences, associate professor of the Department of clinical pharmacology and propedeutics of internal diseases

Russian Federation, 119435, Moscow, 11/4 Rossolimo Str.

Olga V. Ryazantceva

I.M. Sechenov First Moscow State Medical University of the Ministry of Healthcare of Russia (Sechenov University)

Email: ol.ryz@yandex.ru
ORCID iD: 0000-0002-2934-6131

PhD in Medical Sciences, associate professor of the Department of clinical pharmacology and propedeutics of internal diseases

Russian Federation, 119435, Moscow, 11/4 Rossolimo Str.

Svetlana A. Solovieva

I.M. Sechenov First Moscow State Medical University of the Ministry of Healthcare of Russia (Sechenov University)

Email: s.solovieva@outlook.com
ORCID iD: 0000-0002-2013-3455

PhD in Medical Sciences, assistant at the Department of clinical pharmacology and propedeutics of internal diseases

Russian Federation, 119435, Moscow, 11/4 Rossolimo Str.

References

  1. Трухан Д.И., Викторова И.А., Багишева Н.В. Изменения кожи при соматических заболеваниях. Международный журнал прикладных и фундаментальных исследований. 2016; 8(5): 736–740. [Trukhan D.I., Viktorova I.A., Bagisheva N.V. Skin changes in somatic diseases. Mezhdunarodnyy zhurnal prikladnykh i fundamental’nykh issledovaniy = International Journal of Applied and Basic Research. 2016; 8(5): 736–740 (In Russ.)]. EDN: WIMOYJ.
  2. Русак Ю.Э., Горшкова А.В., Ефанова Е.Н. Повышение эффективности терапии хронических дерматозов. РМЖ. 2021; 29(4): 78–80. [Rusak Yu.E., Gorshkova A.V., Efanova E.N. Improving the treatment efficacy of chronic dermatoses. Russkiy meditsinskiy zhurnal = Russian Medical Journal. 2021; 29(4): 78–80 (In Russ.)]. EDN: ZTIODP.
  3. Brazao C., Pimenta R., Queiros C. et al. Cutaneous markers of cardiovascular diseases. Acta Med Port. 2022; 35(12): 899–907. https://dx.doi.org/10.20344/amp.18108.
  4. Газданова А.А., Перков А.В., Лобанова К.К. с соавт. Дерматологические проявления ревматических заболеваний. Клиническая дерматология и венерология. 2022; 21(4): 548–554. [Gazdanova A.A., Perkov A.V., Lobanova K.K. et al. Dermatological manifestations of rheumatic diseases. Klinicheskaya dermatologiya i venerologiya = Russian Journal of Clinical Dermatology and Venereology. 2022; 21(4): 548–554 (In Russ.)]. https://dx.doi.org/10.17116/klinderma202221041548. EDN: VRZFOY.
  5. Газданова А.А., Городецкая Г.И., Перков А.В. с соавт. Кожные проявления эндокринных заболеваний. Клиническая дерматология и венерология. 2022; 21(2): 230–237. [Gazdanova A.A., Gorodetskaya G.I., Perkov A.V. et al. Cutaneous manifestations of endocrine disorders. Klinicheskaya dermatologiya i venerologiya = Russian Journal of Clinical Dermatology and Venereology. 2022; 21(2): 230–237 (In Russ.)]. https://dx.doi.org/10.17116/klinderma202221021230. EDN: EAFAAU.
  6. Иванов О.Л., Новоселов А.В., Новоселов В.С. Кожный синдром в практике гастроэнтеролога поликлиники. Терапевтический архив. 2009; 81(1): 25–29. [Ivanov O.L., Novoselov A.V., Novoselov V.S. Cutaneous syndrome in practice of the gastroenterologist of the outpatient clinic. Terapevticheskiy arkhiv = Therapeutic Archive. 2009; 81(1): 25–29 (In Russ.)]. EDN: HEIBDB.
  7. Antonelli E., Bassotti G., Tramontana M. et al. Dermatological manifestations in inflammatory bowel diseases. J Clin Med. 2021; 10(2): 364. https://dx.doi.org/10.3390/jcm10020364.
  8. Lalosevic M.S., Lalosevic J., Stjepanovic M. et al. Drug induced cutaneous manifestations due to treatment of gastrointestinal disorders. Curr Drug Metab. 2021; 22(2): 99–107. https://dx.doi.org/10.2174/1389200221999201116143109.
  9. Lekwuttikarn R., Teng J.M.C. Cutaneous manifestations of nutritional deficiency. Curr Opin Pediatr. 2018; 30(4): 505–13. https://dx.doi.org/10.1097/MOP.0000000000000652.
  10. Yi J.Z., Chen S.X., Lukac D., McGee J.S. Systemic comorbidities of rosacea: practice gaps among dermatologists. Arch Dermatol Res. 2022; 314(10): 995–97. https://dx.doi.org/10.1007/s00403-021-02279-y.
  11. Матушевская Е.В., Комиссаренко И.А. Кожные проявления заболеваний желудочно-кишечного тракта. Экспериментальная и клиническая гастроэнтерология. 2019; (6): 86–92. [Matushevskaya E.V., Komissarenko I.A. Cutaneous manifestations of diseases of the gastrointestinal tract. Eksperimental’naya i klinicheskaya gastroenterologiya = Experimental and Clinical Gastroenterology. 2019; (6): 86–92 (In Russ.)]. https://dx.doi.org/10.31146/1682-8658-ecg-166-6-86-92. EDN: HWKDRH.
  12. Максимова Е.В., Кляритская И.Л., Григоренко Е.И. с соавт. Дерматологические проявления инфекции Helicobacter pylori. Крымский терапевтический журнал. 2019; (4): 47–52. [Maksimova E.V., Kliaritskaia I.L., Grigorenko E.I. et al. Dermatological manifestations of Helicobacter pylori infection. Krymskiy terapevticheskiy zhurnal = Crimean Therapeutic Journal. 2019; (4): 47–52 (In Russ.)]. EDN: FFPMOW.
  13. Zheleznov S., Urzhumtseva G., Petrova N. et al. Gastritis can cause and trigger chronic spontaneous urticaria independent of the presence of Helicobacter pylori. Int Arch Allergy Immunol. 2018; 175(4): 246–51. https://dx.doi.org/10.1159/000487669.
  14. Curth H.M., Dinter J., Nigemeier K. et al. Effects of Helicobacter pylori eradication in chronic spontaneous urticaria: Results from a retrospective cohort study. Am J Clin Dermatol. 2015; 16(6): 553–58. https://dx.doi.org/10.1007/s40257-015-0152-6.
  15. Wang F.Y., Chi C.C. Rosacea, germs, and bowels: A review on gastrointestinal comorbidities and gut-skin axis of rosacea. Adv Ther. 2021; 38(3): 1415–24. https://dx.doi.org/10.1007/s12325-021-01624-x.
  16. Searle T., Ali F.R., Carolides S., Al-Niaimi F. Rosacea and the gastrointestinal system. Australas J Dermatol. 2020; 61(4): 307–11. https://dx.doi.org/10.1111/ajd.13401.
  17. Le S.T., Toussi A., Maverakis N. et al. The cutaneous and intestinal microbiome in psoriatic disease. Clin Immunol. 2020; 218: 108537. https://dx.doi.org/10.1016/j.clim.2020.108537.
  18. Molnar J., Mallonee C.J., Stanisic D. et al. Hidradenitis suppurativa and 1-carbon metabolism: Role of gut microbiome, matrix metalloproteinases, and hyperhomocysteinemia. Front Immunol. 2020; 11: 1730. https://dx.doi.org/10.3389/fimmu.2020.01730.
  19. Атопический дерматит в схемах и таблицах. Педиатрия. Приложение к журналу Consilium Medicum. 2017; (1): 98–102. [Atopic dermatitis in charts and tables. Pediatriya. Prilozheniye k zhurnalu Consilium Medicum = Pediatrics. Supplement to Consilium Medicum. 2017; (1): 98–102 (In Russ.)]. EDN: YPSTML.
  20. Li W., Yosipovitch G. The role of the microbiome and microbiome-derived metabolites in atopic dermatitis and non-histaminergic itch. Am J Clin Dermatol. 2020; 21(1): 44–50. https://dx.doi.org/10.1007/s40257-020-00538-8.
  21. Walter A., Seegraber M., Wollenberg A. Food-related contact dermatitis, contact urticaria, and atopy patch test with food. Clin Rev Allergy Immunol. 2019; 56(1): 19–31. https://dx.doi.org/10.1007/s12016-018-8687-y.
  22. Lopez C.M., Yarrarapu S.N.S., Mendez M.D. Food allergies. 2021; In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021. PMID: 29489188.
  23. [Suh H.Y., Lee W.J., Na S.Y. [Dermatologic manifestations in inflammatory bowel disease. Korean J Gastroenterol. 2019; 73(5): 285–93 (In Korean)]. https://dx.doi.org/10.4166/kjg.2019.73.5.285
  24. Jansen F.M., Vavricka S.R., den Broeder A.A. et al. Clinical management of the most common extra-intestinal manifestations in patients with inflammatory bowel disease focused on the joints, skin and eyes. United European Gastroenterol J. 2020; 8(9): 1031–44. https://dx.doi.org/10.1177/2050640620958902.
  25. Sun Y., Li Y., Zhang J. The causal relationship between psoriasis, psoriatic arthritis, and inflammatory bowel diseases. Sci Rep. 2022; 12(1): 20526. https://dx.doi.org/10.1038/s41598-022-24872-5.
  26. Bao B., Zhu C., Shi J., Lu C. Causal association between inflammatory bowel disease and hidradenitis suppurativa: A two-sample bidirectional Mendelian randomization study. Front Immunol. 2023; 14: 1071616. https://dx.doi.org/10.3389/fimmu.2023.1071616.
  27. Huda S.A., Kahlown S., Jilani M.H. et al. The Sweet syndrome as a cutaneous manifestation of Crohn’s disease. Proc (Bayl Univ Med Cent). 2020; 33(3): 395–97. https://dx.doi.org/10.1080/08998280.2020.1753457.
  28. [Bres A., Galvez P., Fricain J.C. Cutaneous manifestation enabling early diagnosis of Crohn’s disease. Ann Dermatol Venereol. 2020; 147(12): 912–13 (In French)]. https://dx.doi.org/10.1016/j.annder.2020.06.019.
  29. Diaconescu S., Strat S., Balan G.G. et al. Dermatological manifestations in pediatric inflammatory bowel disease. Medicina (Kaunas). 2020; 56(9): 425. https://dx.doi.org/10.3390/medicina56090425.
  30. Chatzinasiou F., Polymeros D., Panagiotou M. et al. Generalized pyoderma gangrenosum associated with ulcerative colitis: Successful treatment with infliximab and azathioprine. Acta Dermatovenerol Croat. 2016; 24(1): 83–85.
  31. Lee H., Song W.J., Koh S.J., Park H. Epidemiological association between alopecia areata and celiac disease: A meta-analysis. J Dermatol. 2022; 49(11): e399–400. https://dx.doi.org/10.1111/1346-8138.16478.
  32. Rodrigo L., Beteta-Gorriti V., Alvarez N. et al. Cutaneous and mucosal manifestations associated with celiac disease. Nutrients. 2018; 10(7): 800. https://dx.doi.org/10.3390/nu10070800.
  33. Lebwohl B., Soderling J., Roelstraete B. et al. Risk of skin disorders in patients with celiac disease: A population-based cohort study. J Am Acad Dermatol. 2021; 85(6): 1456–64. https://dx.doi.org/10.1016/j.jaad.2020.10.079.
  34. Persechino F., Galli G., Persechino S. et al. Skin manifestations and coeliac disease in paediatric population. Nutrients. 2021; 13(10): 3611. https://dx.doi.org/10.3390/nu13103611.
  35. Antunes C., Singhal M. Whipple disease. 2021. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. 2021. PMID: 28722966.
  36. Munjal Y., Munjal S.D., Tiwari R. Whipple’s disease: Rare case of malabsorption with hyperpigmentation in a female. Indian J Pathol Microbiol. 2021; 64(4): 788–90. https://dx.doi.org/10.4103/IJPM.IJPM_887_20.
  37. Borretta L., Walsh N.M., Bakowsky V. et al. A case of Whipple disease with cutaneous manifestations. Am J Dermatopathol. 2021; 43(9): e10 –6. https://dx.doi.org/10.1097/DAD.0000000000001925.
  38. Solis-Garcia Del Pozo J., de Cabo C., Solera J. Gastrointestinal manifestations in Satoyoshi syndrome: A systematic review. Orphanet J Rare Dis. 2020; 15(1): 115. https://dx.doi.org/10.1186/s13023-020-01395-8.
  39. Rudnicka L., Kwiatkowska M., Rakowska A. et al. Alopecia areata. How not to miss Satoyoshi syndrome? J Dermatol. 2014; 41(11): 951–56. https://dx.doi.org/10.1111/1346-8138.12633.
  40. Sanghvi S.Y., Schwartz R.A. Leiner’s disease (erythroderma desquamativum): A review and approach to therapy. Dermatol Ther. 2021; 34(1): e14510. https://dx.doi.org/10.1111/dth.14510.
  41. Halabi I., Barohom M.N., Peleg S. et al. Case report: Severe hypocalcemic episodes due to autoimmune enteropathy. Front Endocrinol (Lausanne). 2021; 12 :645279. https://dx.doi.org/10.3389/fendo.2021.645279.
  42. Silverio Ade O., Guimaraes D.C., Elias L.F. et al. Are the spider angiomas skin markers of hepatopulmonary syndrome? Arq Gastroenterol. 2013; 50(3): 175–79. https://dx.doi.org/10.1590/S0004-28032013000200031.
  43. Liu Y., Zhao Y., Gao X. et al. Recognizing skin conditions in patients with cirrhosis: A narrative review. Ann Med. 2022; 54(1): 3017–29. https://dx.doi.org/10.1080/07853890.2022.2138961.
  44. Dogra S., Jindal R. Cutaneous manifestations of common liver diseases. J Clin Exp Hepatol. 2011; 1(3): 177–84. https://dx.doi.org/10.1016/S0973-6883(11)60235-1.
  45. Patel A.D., Katz K., Gordon K.B. Cutaneous manifestations of chronic liver disease. Clin Liver Dis. 2020; 24(3): 351–60. https://dx.doi.org/10.1016/j.cld.2020.04.003.
  46. Fernandez-Somoza J.M., Ginarte M., Otero E. et al. Clinical and capillaroscopic findings in patients with liver disease and proximal apparent leukonychia (Terry nails and its variants). Medicine (Baltimore). 2021; 100(22): e26207. https://dx.doi.org/10.1097/MD.0000000000026207.
  47. Wang C.R., Tsai H.W. Human hepatitis viruses-associated cutaneous and systemic vasculitis. World J Gastroenterol. 2021; 27(1): 19–36. https://dx.doi.org/10.3748/wjg.v27.i1.19.
  48. [Alvarez Aguilar P.A., Angulo Mora S. Xanthomas and xanthelasmas in primary biliary cholangitis. Med Clin (Barc). 2019; 153(1): 46 (In English, Spanish)]. https://dx.doi.org/10.1016/j.medcli.2018.10.003.
  49. Bhandari A., Mahajan R. Skin changes in cirrhosis. J Clin Exp Hepatol. 2022; 12(4): 1215–24. https://dx.doi.org/10.1016/j.jceh.2021.12.013.
  50. Miulescu R., Balaban D.V., Sandru F., Jinga M. Cutaneous manifestations in pancreatic diseases – A review. J Clin Med. 2020; 9(8): 2611. https://dx.doi.org/10.3390/jcm9082611.
  51. Szabo C.E., Man O.I., Serban R.S. et al. Bruising as the first sign of exocrine pancreatic insufficiency in infancy. Med Pharm Rep. 2019; 92(2): 200–4. https://dx.doi.org/10.15386/mpr-1231.
  52. Еремина Т.А., Позднякова О.Н. Хронические дерматозы, ассоциированные с синдромом мальабсорбции. Медицина и образование в Сибири. 2012; (1): 22. [Eremina T.A., Pozdnyakova O.N. Chronic dermatosis associated with malabsorbtion syndrom. Meditsina i obrazovaniye v Sibiri = Medicine and Education in Siberia. 2012; (1): 22 (In Russ.)]. EDN: PBZZHV.
  53. Gueant J.L., Gueant-Rodriguez R.M., Alpers D.H. Vitamin B12 absorption and malabsorption. Vitam Horm. 2022; 119: 241–74. https://dx.doi.org/10.1016/bs.vh.2022.01.016.
  54. Normatov I., Sentongo T. Pancreatic malnutrition in children. Pediatr Ann. 2019; 48(11): e441–47. https://dx.doi.org/10.3928/19382359-20191018-01
  55. Nosewicz J., Sparks A., Hart P.A. et al. The evaluation and management of macronutrient deficiency dermatoses. J Am Acad Dermatol. 2022; 87(3): 640–47. https://dx.doi.org/10.1016/j.jaad.2022.04.007.
  56. Ikuse T., Kudo T., Arai K. et al. Shwachman–Diamond syndrome: Nationwide survey and systematic review in Japan. Pediatr Int. 2018; 60(8): 719–26. https://dx.doi.org/10.1111/ped.13601.
  57. Сереброва С.Ю. Гастроэнтерологические аспекты муковисцидоза. РМЖ. 2008; (1): 1. [Serebrova S.Yu. Gastroenterological aspects of cystic fibrosis. Russkiy meditsinskiy zhurnal = Russian Medical Journal. 2008; (1): 1 (In Russ.)].
  58. [Morfin-Maciel B.M., Garcia-de la Puente S., Huante-Anaya A., Bojorquez-Ochoa A. The prevalence of allergic diseases in children with short bowel syndrome. Rev Alerg Mex. 2020; 67(4): 329–37 (In Spanish)]. https://dx.doi.org/10.29262/ram.v67i4.801
  59. Pironi L., Corcos O., Forbes A. et al.; ESPEN Acute and Chronic Intestinal Failure Special Interest Groups. Intestinal failure in adults: Recommendations from the ESPEN expert groups. Clin Nutr. 2018; 37(6 Pt A): 1798–809. https://dx.doi.org/10.1016/j.clnu.2018.07.036
  60. Zhu C., Li Y. An updated overview of glucagon-like peptide-2 analog trophic therapy for short bowel syndrome in adults. J Int Med Res. 2022; 50(3): 3000605221086145. https://dx.doi.org/10.1177/03000605221086145
  61. Garcovich S., De Simone C., Giovanardi G. et al. Post-bariatric surgery hidradenitis suppurativa: A new patient subset associated with malabsorption and micronutritional deficiencies. Clin Exp Dermatol. 2019; 44(3): 283–89. https://dx.doi.org/10.1111/ced.13732.
  62. Lemieux L.M., Surampudi V. Severe vitamin A deficiency after biliopancreatic diversion. J Investig Med High Impact Case Rep. 2019; 7: 2324709619888051. https://dx.doi.org/10.1177/2324709619888051

Supplementary files

Supplementary Files
Action
1. JATS XML
Download
2. Fig.1.

Download (78KB)
Indexing metadata
3. Fig.2.

Download (168KB)
Indexing metadata
4. Fig.3.

Download (97KB)
Indexing metadata
5. Fig.4.

Download (97KB)
Indexing metadata
6. Fig.5.

Download (151KB)
Indexing metadata

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies